Not yet clear

This product belongs to the macrolide antibiotics, which is the dodecyl sulfate of erythromycin propionate. It has antibacterial activity against Staphylococcus, various groups of streptococci and Gram-positive bacilli. Neisseria, Haemophilus influenzae, Bordetella pertussis, etc. may also be sensitive to this product. This product also has antibacterial activity against various anaerobic bacteria except Bacteroides fragilis and Fusobacterium; it also has inhibitory effects on Legionella, Campylobacter fetus, some spirochetes, Mycoplasma pneumoniae, Rickettsia and Chlamydia. This product is an antibacterial agent, but it also has a bactericidal effect on some bacteria at high concentrations. This product can pass through the bacterial cell membrane and reversibly bind to the 50S subunit of the bacterial ribosome near the donor site (P site), blocking the transfer RNA (t-RNA) binding to the P site, and also blocking the displacement of the polypeptide chain from the acceptor site (A site) to the P site, thereby inhibiting bacterial protein synthesis. This product is only effective against bacteria with active division.

It has antibacterial effect on most Gram-positive and Gram-negative bacteria, and inhibits the early synthesis of bacterial cell walls, thereby blocking the synthesis of bacterial cell walls and causing their death.

It is a non-narcotic analgesic with analgesic, sedative, hypnotic and tranquilizing effects. Its analgesic effect is stronger than that of general antipyretic analgesics. The analgesic effect appears 10 minutes after taking the medicine and can last for 2-5 hours. It has a good analgesic effect on dull pain caused by the gastrointestinal system, but has a poor effect on severe pain such as trauma. It is also effective for menstrual pain, and is more suitable for insomnia, especially insomnia caused by pain, with no sequelae after waking up.